More about

Osteoporosis

News
February 16, 2020
1 min read
Save

Effects of endocrine-disrupting chemicals extend to obesity, osteoporosis, IQ and beyond

Effects of endocrine-disrupting chemicals extend to obesity, osteoporosis, IQ and beyond

Although causality is difficult to prove definitively, mounting evidence suggests adverse health consequences of endocrine-disrupting among humans. Recent research links these ubiquitous compounds to pediatric obesity, diabetes, osteoporosis and more.

News
February 12, 2020
1 min read
Save

Top stories in endocrinology: Phthalates impact testosterone levels, bigger arm muscles reduce osteoporosis risk

A cross-sectional analysis of more than 1,400 men suggested that phthalate metabolites from plastics and personal care products influenced testosterone levels — a top story in endocrinology last week.

News
February 07, 2020
2 min read
Save

Frailty plus trabecular bone score fails to improve fracture risk prediction

Frailty plus trabecular bone score fails to improve fracture risk prediction

Combining indices of frailty and trabecular bone score did not yield improved predictive accuracy for major osteoporotic fracture risk when compared with frailty alone or trabecular bone score alone, according to findings published in the Journal of Bone and Mineral Research.

News
February 06, 2020
1 min read
Save

Men with bigger arm muscles have lower osteoporosis risk

Larger mid-arm muscle circumference is associated with lower risk for osteoporosis among men, according to findings published in the Archives of Gerontology and Geriatrics.

News
January 31, 2020
3 min read
Save

Zoledronate infusion preserves BMD gains after denosumab discontinuation for women with osteoporosis

Zoledronate infusion preserves BMD gains after denosumab discontinuation for women with osteoporosis

Postmenopausal women with osteoporosis who received a single infusion of zoledronate after 2 to 5 years of denosumab therapy retained more than half of bone mineral density gained before stopping treatment with no increase in vertebral fractures, according to findings published in the Journal of Bone and Mineral Research.

News
January 20, 2020
2 min read
Save

Pheochromocytoma, paraganglioma underrecognized cause of secondary osteoporosis

Pheochromocytoma, paraganglioma underrecognized cause of secondary osteoporosis

Adults with pheochromocytoma or paraganglioma are nearly five times more likely to experience a vertebral fracture, a hallmark of osteoporosis, when compared with adults with nonfunctional adrenal tumors, according to findings published in Bone.

News
January 20, 2020
3 min read
Save

Recent fracture ‘addressable risk factor’ for new fracture

Recent fracture ‘addressable risk factor’ for new fracture

Women who experience a first fragility fracture are at significant risk for experiencing subsequent fractures, particularly in the 2 years after the fracture, according to findings published in the Journal of Bone and Mineral Research.

News
January 14, 2020
2 min read
Save

Polygenic disease may explain increased bone fragility among children without osteogenesis imperfecta

Polygenic disease may explain increased bone fragility among children without osteogenesis imperfecta

A cohort of children presenting with increased bone fragility and no extraskeletal signs of osteogenesis imperfecta tended to have a collection of common gene variants that predispose to osteoporotic fracture rather than a monogenic etiology of their condition, according to findings published in the Journal of Bone and Mineral Research.

News
January 07, 2020
4 min read
Save

Delays between denosumab injections may worsen BMD response

Delays between denosumab injections may worsen BMD response

A longer interval between denosumab injections is associated with suboptimal bone mineral density response at the spine and total hip, and strategies to improve the timely administration of denosumab in real-world settings are needed, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

News
December 30, 2019
2 min read
Save

Elevated FSH, lower estradiol levels associated with greater osteoporosis risk among men with type 2 diabetes

Elevated FSH, lower estradiol levels associated with greater osteoporosis risk among men with type 2 diabetes

Men with type 2 diabetes are more likely to develop osteoporosis if they have elevated follicle-stimulating hormone, or FSH, whereas elevated estradiol is associated with lower osteoporosis risk, according to findings published in the Journal of Diabetes.

View more